The integration with Face2Gene increases the diagnostic power of PreventionGenetics’ genetic testing using artificial intelligence and computer vision technology, which highlights genetic variants that are highly correlated with disease and the patient’s clinical phenotype.
| |
| [29-November-2017] |
| MARSHFIELD, Wis., Nov. 29, 2017 /PRNewswire/ -- PreventionGenetics today announces integration of their genetic testing and interpretation services with FDNA’s (www.fdna.com) Face2Gene suite of applications (www.face2gene.com). The integration with Face2Gene increases the diagnostic power of PreventionGenetics’ genetic testing using artificial intelligence and computer vision technology, which highlights genetic variants that are highly correlated with disease and the patient’s clinical phenotype. “PreventionGenetics uses the most advanced technologies available to ensure patients of all kinds get the answers they need,” said James Weber, Ph.D., founder and president of PreventionGenetics. “With the cost of sequencing continuing to decline, and technologies like FDNA’s Face2Gene improving the insights available from testing, patients and providers are poised to benefit greatly.” Since the product’s inception, Face2Gene has analyzed facial images of tens-of-thousands of patients for more than 2,500 syndromes, and non-facial phenotypes for more than 10,000 syndromes, linking the analysis to the disease-causing genetic variations. “Bringing FDNA’s artificial intelligence and facial analysis technologies to PreventionGenetics and other leading labs is facilitating a new age in precision medicine,” said Dekel Gelbman, CEO, FDNA. “With this integration, clinicians can identify malfunctioning genetics for their patients faster, opening the door to therapy.” Face2Gene is currently used by more than 70% of clinical geneticists worldwide to identify syndromes, genes and phenotypes that correlate with patients’ facial and clinical analysis. About PreventionGenetics Founded in 2004 and located in Marshfield, Wisconsin, PreventionGenetics is a CLIA and ISO 15189:2012 accredited clinical DNA testing laboratory. PreventionGenetics provides patients with sequencing and deletion/duplication tests for nearly all clinically relevant genes. These tests include our powerful and comprehensive whole exome sequencing test, PGxome™. PreventionGenetics also offers DNA Banking (PGDNABank), long-term storage of a person’s DNA. DNA Banking is available direct-to-consumer. Visit our DNA Banking website. About FDNA and Face2Gene FDNA is the developer of Face2Gene, a clinical suite of next-generation phenotyping applications that facilitates comprehensive and precise genetic evaluations. Face2Gene uses facial analysis, deep learning and artificial intelligence to transform big data into actionable genomic insights to improve and accelerate diagnostics and therapeutics. With the world’s largest network of clinicians, labs and researchers creating one of the fastest growing and most comprehensive genomic databases, FDNA is changing the lives of patients with diseases with genetic causes. For more information, visit www.FDNA.com. Face2Gene is a registered trademark of FDNA INC. View original content with multimedia:http://www.prnewswire.com/news-releases/preventiongenetics-announces-integration-with-fdnas-deep-learning-platform-face2gene-to-increase-the-diagnostic-power-of-genetic-testing-300563700.html SOURCE PreventionGenetics |
